3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
10
Prostatic Neoplasms
7
Sarcoma
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Pancreatic Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
3
Urinary Bladder Neoplasms
2
Endometrial Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Breast Carcinoma In Situ
2
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Prostate Adenocarcinoma
1
Pituitary Neoplasms
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Meningioma
1
Male Urogenital Diseases
1
Lymphedema
1
Interventions
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Biopsy
2
ulixertinib
1
tipifarnib
1
tazemetostat
1
selpercatinib
1
pembrolizumab
1
palbociclib
1
olaparib
1
larotrectinib
1
ivosidenib
1
erdafitinib
1
ensartinib
1
cobimetinib
1
X-Rays
1
Vemurafenib
1
Phantoms, Imaging
1
Nuclear Medicine Department, Hospital
1
Lenalidomide
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytic Sarcoma
×
Radiation Dose Hypofractionation
×
1 year
×
Clear all
No trials found.